Systemic lupus erythematosus induced by aminoglutethimide.
作者信息
McCraken M, Benson E A, Hickling P
出版信息
Br Med J. 1980 Nov 8;281(6250):1254. doi: 10.1136/bmj.281.6250.1254.
Abstract
摘要
相似文献
1
Systemic lupus erythematosus induced by aminoglutethimide.氨鲁米特诱发的系统性红斑狼疮。
Br Med J. 1980 Nov 8;281(6250):1254. doi: 10.1136/bmj.281.6250.1254.
2
Dual pharmacological effect of aminoglutethamide.氨鲁米特的双重药理作用。
Lupus. 1994 Oct;3(5):435. doi: 10.1177/096120339400300513.
3
Effect of aminoglutethemide on the activity of a case of a connective tissue disorder with features of systemic lupus erythematosus.氨鲁米特对一例具有系统性红斑狼疮特征的结缔组织病患者活性的影响。
Lupus. 1993 Dec;2(6):387. doi: 10.1177/096120339300200611.
4
Pancytopenia induced by aminoglutethimide in the treatment of breast cancer.氨鲁米特治疗乳腺癌所致的全血细胞减少
Cancer Treat Rep. 1978 Oct;62(10):1581-3.
5
Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.他莫昔芬与氨鲁米特及他莫昔芬联合氨鲁米特治疗绝经后晚期乳腺癌的随机试验
Oncology. 1988;45(5):350-3. doi: 10.1159/000226639.
6
Aminoglutethimide in the management of advanced breast cancer.氨鲁米特在晚期乳腺癌治疗中的应用
Eur J Cancer (1965). 1980;Suppl 1:99-101.
7
Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studies.与氨鲁米特相关的粒细胞缺乏症：药理学与骨髓研究
Br J Cancer. 1986 Jul;54(1):119-22. doi: 10.1038/bjc.1986.160.
8
Agranulocytosis induced by aminoglutethimide.氨鲁米特诱发的粒细胞缺乏症。
Acta Clin Belg. 1988;43(2):146-8. doi: 10.1080/17843286.1988.11717923.
9
Medical adrenalectomy with aminoglutethimide-cortisol in the treatment of metastatic breast carcinoma.
Eur J Cancer (1965). 1980;Suppl 1:103-6.
10
Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
Anticancer Res. 1986 Sep-Oct;6(5):1065-8.
引用本文的文献
1
Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review.芳香化酶抑制剂诱发乳腺癌患者自身免疫性疾病：一项综述。
J Adv Res. 2016 Sep;7(5):719-726. doi: 10.1016/j.jare.2016.04.001. Epub 2016 Apr 23.
2
First generation aromatase inhibitors--aminoglutethimide and testololactone.第一代芳香化酶抑制剂——氨鲁米特和睾内酯。
Breast Cancer Res Treat. 1994;30(1):57-80. doi: 10.1007/BF00682741.
3
Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.氨鲁米特作为乳腺癌内分泌治疗的作用机制
Drugs. 1988 Jun;35(6):685-710. doi: 10.2165/00003495-198835060-00005.
4
Aromatase inhibitors in malignant diseases of aging.芳香化酶抑制剂在衰老相关恶性疾病中的应用
Drugs Aging. 1992 Nov-Dec;2(6):530-45. doi: 10.2165/00002512-199202060-00008.
本文引用的文献
1
Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer.英国和日本女性的甲状腺及其他自身抗体：一项乳腺癌的流行病学研究
Br Med J. 1976 Jan 31;1(6004):257-9. doi: 10.1136/bmj.1.6004.257.
2
Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis.乳腺癌患者的自身抗体。与预后的相关性。
Clin Exp Immunol. 1975 Mar;19(3):417-22.
3
Autoantibodies in early breast cancer: a stage-related phenomenon?早期乳腺癌中的自身抗体：一种与分期相关的现象？
Br J Cancer. 1978 Sep;38(3):461-3. doi: 10.1038/bjc.1978.230.
4
Lupus-like syndrome associated with carcinoma of the breast.与乳腺癌相关的狼疮样综合征。
Arch Intern Med. 1977 Apr;137(4):532-5.
Zotero 插件